Outcome MeasureOther

CAARS

Conners Adult ADHD Rating Scales

1 Paper in Blossom

Outcome Data Across Studies

Reported results for CAARS across 1 study with quantitative data.

Outcome data across 2 study arm–timepoint observations
SD
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial
2025Secondary
MM-120(experimental)02723.05.0—
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial
2025Secondary
Placebo(inactive)02622.06.0—

Papers Using CAARS

Open Accessindividual

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial

In a 6‑week, multicentre, double‑blind randomised phase 2A trial of 53 adults with moderate–severe ADHD, twice‑weekly low‑dose LSD (20 μg) was physically safe and psychologically well tolerated. However, LSD did not reduce ADHD symptoms more than placebo on the AISRS.

Published
Journal
JAMA Psychiatry
Authors
Mueller, L., de Jesus, N. M. S., Schmid, Y., Müller, F., Becker, A. M., Klaiber, A., Straumann, I., Luethi, D., Haijen, E. C. H. M., Hurks, P. P. M., Kuypers, K. P. C., Liechti, M. E.

Quick Facts

Full Name
Conners Adult ADHD Rating Scales
Domain
Other
Papers Indexed
1
Score Range
0–198
Interpretation
Lower = better
Unit
points
All Measures